| Home > Publications Database > Analysis of PTEN Antagonistic Peptides (PAPs) in Neuronal Growth and Traumatic Brain Injury (TBI). |
| Journal Article | DZNE-2026-00890 |
; ; ; ; ; ; ; ; ; ;
2026
American Chemical Soc.
Columbus, Ohio
This record in other databases:
Please use a persistent id in citations: doi:10.1021/acs.biomac.6c00695
Abstract: PTEN (phosphatase and tensin homologue) is an established cellular growth brake whose inhibition stimulates regeneration of injured neurons in rodent models. Herein, we employed peptide-based PTEN inhibition targeting PTEN's phosphatase activity. Therefore, a fusion peptide (PAP2-TAT) of PAP2 (PTEN antagonistic peptide 2) with TAT (transactivator of transcription) was used to enable cellular entry. PAP2-TAT was not cytotoxic and entered the cytoplasm of primary mouse neurons, where it enhanced neurite growth, growth cone size, and synaptophysin abundance. PAP2-TAT modestly elevated P-AKT and more strongly elevated P-ERK levels. Furthermore, STATs (signal transducer and activator of transcription) were phosphorylated after PAP2-TAT administration. So far, PAPs have not been employed in traumatic brain injury (TBI). In a mouse TBI model, a single PAP2-TAT injection improved single parameters of gait impairments but had no impact on neuroinflammation and TBI-associated weight loss. In summary, peptide-based PTEN inhibition aids neuronal cell growth and regeneration after brain injury.
Keyword(s): Animals (MeSH) ; PTEN Phosphohydrolase: antagonists & inhibitors (MeSH) ; PTEN Phosphohydrolase: metabolism (MeSH) ; Brain Injuries, Traumatic: drug therapy (MeSH) ; Brain Injuries, Traumatic: pathology (MeSH) ; Brain Injuries, Traumatic: metabolism (MeSH) ; Mice (MeSH) ; Peptides: pharmacology (MeSH) ; Peptides: chemistry (MeSH) ; Neurons: drug effects (MeSH) ; Neurons: metabolism (MeSH) ; Neurons: pathology (MeSH) ; Male (MeSH) ; Mice, Inbred C57BL (MeSH) ; PTEN Phosphohydrolase ; Peptides ; Pten protein, mouse
|
The record appears in these collections: |